Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.

Xiao L, Tong M, Jin Y, Huang W, Li Z.

Mol Biol Rep. 2013 Feb;40(2):1835-41. doi: 10.1007/s11033-012-2238-z. Epub 2012 Oct 21.

PMID:
23096092
2.

Gene-diet interactions on plasma lipid levels in the Inuit population.

Rudkowska I, Dewailly E, Hegele RA, Boiteau V, Dubé-Linteau A, Abdous B, Giguere Y, Chateau-Degat ML, Vohl MC.

Br J Nutr. 2013 Mar 14;109(5):953-61. doi: 10.1017/S0007114512002231. Epub 2012 Jul 5.

PMID:
23021345
3.

CYP1B1 and hormone-induced cancer.

Gajjar K, Martin-Hirsch PL, Martin FL.

Cancer Lett. 2012 Nov 1;324(1):13-30. doi: 10.1016/j.canlet.2012.04.021. Epub 2012 May 2. Review.

PMID:
22561558
4.

Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study.

Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Krüger T, Ghisari M, Mulvad G, Kern P, Nzulumiki P, Dewailly E.

Environ Health. 2011 Oct 6;10:88. doi: 10.1186/1476-069X-10-88.

5.

The catechol-O-methyltransferase gene: its regulation and polymorphisms.

Tunbridge EM.

Int Rev Neurobiol. 2010;95:7-27. doi: 10.1016/B978-0-12-381326-8.00002-8. Review.

PMID:
21095457
6.

Biomonitoring in Greenland: human biomarkers of exposure and effects - a short review.

Bonefeld-Jorgensen EC.

Rural Remote Health. 2010 Apr-Jun;10(2):1362. Epub 2010 Jun 18. Review.

7.

Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls.

Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q.

Breast Cancer Res Treat. 2010 Jun;121(3):719-25. doi: 10.1007/s10549-009-0650-4. Epub 2009 Nov 22.

PMID:
20464630
8.

Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice.

La Merrill M, Harper R, Birnbaum LS, Cardiff RD, Threadgill DW.

Environ Health Perspect. 2010 May;118(5):596-601. doi: 10.1289/ehp.0901047.

9.

2-Methoxyestradiol--biology and mechanism of action.

Mueck AO, Seeger H.

Steroids. 2010 Oct;75(10):625-31. doi: 10.1016/j.steroids.2010.02.016. Epub 2010 Mar 7. Review.

PMID:
20214913
10.

COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.

Ding H, Fu Y, Chen W, Wang Z.

Breast Cancer Res Treat. 2010 Aug;123(1):265-70. doi: 10.1007/s10549-010-0759-5. Epub 2010 Feb 4.

PMID:
20130981
11.

Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP.

Breast Cancer Res Treat. 2010 Jul;122(2):459-69. doi: 10.1007/s10549-009-0694-5. Epub 2009 Dec 25. Review. Erratum in: Breast Cancer Res Treat. 2012 Feb;131(3):1083.

PMID:
20035380
12.

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.

Yao L, Fang F, Wu Q, Zhong Y, Yu L.

Breast Cancer Res Treat. 2010 Jul;122(1):237-42. doi: 10.1007/s10549-009-0689-2. Epub 2009 Dec 24.

PMID:
20033481
13.

Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.

Bozina N, Bradamante V, Lovrić M.

Arh Hig Rada Toksikol. 2009 Jun;60(2):217-42. doi: 10.2478/10004-1254-60-2009-1885. Review.

PMID:
19581216
14.

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.

Breast Cancer Res Treat. 2010 Jan;119(2):463-74. doi: 10.1007/s10549-009-0407-0. Epub 2009 May 8. Erratum in: Breast Cancer Res Treat. 2010 Jan;119(2):475.

PMID:
19424794
15.

Regulation of CYP1A1 by heavy metals and consequences for drug metabolism.

Anwar-Mohamed A, Elbekai RH, El-Kadi AO.

Expert Opin Drug Metab Toxicol. 2009 May;5(5):501-21. doi: 10.1517/17425250902918302 . Review.

PMID:
19416086
16.

Polychlorinated biphenyls 105 and 118 form thyroid hormone receptor agonists after cytochrome P4501A1 activation in rat pituitary GH3 cells.

Gauger KJ, Giera S, Sharlin DS, Bansal R, Iannacone E, Zoeller RT.

Environ Health Perspect. 2007 Nov;115(11):1623-30.

17.

The COMT val158met polymorphism is associated with prevalent fractures in Swedish men.

Eriksson AL, Mellström D, Lorentzon M, Orwoll ES, Redlund-Johnell I, Grundberg E, Holmberg A, Ljunggren O, Karlsson MK, Ohlsson C.

Bone. 2008 Jan;42(1):107-12. Epub 2007 Sep 18.

PMID:
17962094
18.

Plasma organochlorine concentrations and bone ultrasound measurements: a cross-sectional study in peri-and postmenopausal Inuit women from Greenland.

Côté S, Ayotte P, Dodin S, Blanchet C, Mulvad G, Petersen HS, Gingras S, Dewailly E.

Environ Health. 2006 Dec 21;5:33.

19.

The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis.

Nebert DW, Dalton TP.

Nat Rev Cancer. 2006 Dec;6(12):947-60. Review.

PMID:
17128211
20.

Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review.

Paracchini V, Raimondi S, Gram IT, Kang D, Kocabas NA, Kristensen VN, Li D, Parl FF, Rylander-Rudqvist T, Soucek P, Zheng W, Wedren S, Taioli E.

Am J Epidemiol. 2007 Jan 15;165(2):115-25. Epub 2006 Oct 19. Review.

PMID:
17053044

Supplemental Content

Support Center